Rachel Sanborn, M.D.

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Merck
    Topic:
    Funding for investigator-sponsored trial
    Date added:
    09/26/2022
    Date updated:
    04/29/2024

Pages

Return to 2022 Seattle Multidisciplinary Thoracic Oncology Conference